piracetam has been researched along with fibrinogen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Col-Debeys, C; Crasborn, L; Lavenne-Pardonge, E; Moriau, M; von Frenckell, R | 1 |
| Deberdt, W; Deckmyn, H; Nyström, A; Nyström, E; Stassen, JM; Stockmans, F; Vermylen, J | 1 |
| Bekuzarova, MR; Burd, GS; Iasamanova, AN; Kabanov, AA; Kolesnikova, TI | 1 |
2 trial(s) available for piracetam and fibrinogen
| Article | Year |
|---|---|
Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects.
Topics: Adult; Antithrombin III; Bleeding Time; Blood Coagulation; Blood Viscosity; Cell Membrane; Dose-Response Relationship, Drug; Double-Blind Method; Fibrinogen; Fibrinopeptide A; Humans; Male; Piracetam; Platelet Aggregation; Platelet Count; Platelet Factor 4; Reference Values; Thromboxane B2 | 1993 |
[State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy].
Topics: Adult; Age Factors; Aged; Benzamides; Blood Coagulation Tests; Central Nervous System Stimulants; Cerebrovascular Disorders; Drug Combinations; Fibrinogen; Hemostasis; Hexobendine; Humans; Middle Aged; Neuroprotective Agents; Nootropic Agents; Piracetam; Platelet Aggregation; Theophylline | 1997 |
1 other study(ies) available for piracetam and fibrinogen
| Article | Year |
|---|---|
Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model.
Topics: Animals; Bleeding Time; Cricetinae; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Piracetam; Platelet Aggregation Inhibitors; Platelet Count; Protein Binding; Rats; Thrombosis | 1998 |